IBM director defers fees into 330 Promised Fee Shares on 12/31/2025
International Business Machines Corporation director Andrew N. Liveris reported a routine insider transaction involving deferred director fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
International Business Machines Corporation director Andrew N. Liveris reported a routine insider transaction involving deferred director fees. On 12/31/2025, he acquired 330 Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan at a conversion price of $0.00 per derivative security, each linked to one share of IBM common stock.
The filing shows a related price of $296.21 for the underlying common stock and that, after this transaction, Liveris beneficially owns 43,186 derivative securities directly. Under the plan, Promised Fee Shares and their distributions are deferred until retirement and may be paid out in IBM common stock or cash.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Promised Fee Share | 330 | $296.21 | $98K |
Footnotes (3)
- F1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.
- F2. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.
- F3. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
AI-generated analysis. How Rhea-AI works. Not financial advice.